Medicine and Dentistry
Retinal Pigment Epithelium
100%
Hypoxia
100%
Age Related Macular Degeneration
100%
Clustered Regularly Interspaced Short Palindromic Repeat
100%
Vasculotropin A
100%
Choroidal Neovascularization
100%
Angiogenesis
66%
Epithelium Cell
66%
Aflibercept
66%
Vasculotropin
33%
Therapy Effect
33%
Gene Targeting
33%
Gene Disruption
33%
Genome Editing
33%
Adeno-Associated Virus
33%
Laser-Induced Choroidal Neovascularization
33%
Lachnospiraceae
33%
Endonuclease
33%
Immunology and Microbiology
Mouse Model
100%
Clustered Regularly Interspaced Short Palindromic Repeat
100%
Vasculotropin A
100%
Subretinal Neovascularization
100%
Retinal Pigment Epithelium
100%
Gene Editing
66%
Epithelium Cell
66%
Angiogenesis
66%
Aflibercept
66%
Vasculotropin
33%
Neovascularization (Pathology)
33%
Lachnospiraceae
33%
Gene Disruption
33%
Laser-Induced Choroidal Neovascularization
33%
Adeno Associated Virus
33%
Gene Targeting
33%
Biochemistry, Genetics and Molecular Biology
Mouse Model
100%
CRISPR
100%
Subretinal Neovascularization
100%
Vascular Endothelial Growth Factor A
100%
Angiogenesis
66%
Photosynthetic Pigment
66%
Aflibercept
66%
Endonuclease
33%
Genome Editing
33%
Genome Editing
33%
Neovascularization (Pathology)
33%
Gene Targeting
33%
Lachnospiraceae
33%
Gene Disruption
33%
Adeno Associated Virus
33%
Laser-Induced Choroidal Neovascularization
33%
Vascular Endothelial Growth Factor
33%
RNA
33%
Pharmacology, Toxicology and Pharmaceutical Science
Mouse Model
100%
Subretinal Neovascularization
100%
Hypoxia
100%
Visual Pigment
100%
Age Related Macular Degeneration
100%
Vasculotropin A
100%
Aflibercept
66%
Therapeutic Effect
33%
Adeno Associated Virus
33%
Endonuclease
33%
Vasculotropin
33%
Neovascularization (Pathology)
33%
Laser-Induced Choroidal Neovascularization
33%
Lachnospiraceae
33%
Neuroscience
Age-Related Macular Degeneration
100%
CRISPR
100%
Choroidal Neovascularization
100%
Vasculotropin A
100%
Retinal Pigment Epithelium
66%
Aflibercept
66%
Angiogenesis
66%
In Vivo
33%
Vascular Endothelial Growth Factor
33%
Gene Disruption
33%
Adeno-Associated Virus
33%
Endonuclease
33%